Neuraxis, Inc. (NRXS) Earnings Call Analysis

AMEX · Healthcare · Biotechnology

13/25

Growth 4 Margin 4 Expansion 3 Platform 0 Financial 2

latest quarter score

Earnings Reports

13
NRXS (Neuraxis) Q2 2026: 116% Revenue Growth Driven by Insurance Coverage Expansion and Commercial Execution
August 11, 2026
15
Neuraxis (NRXS) Q1 2026: 33% ASP Lift Signals Reimbursement-Driven Margin Expansion
May 12, 2026
8
NeurAxis (NRXS) Q4 2025: Prior Auth Submissions Surge 10x as CPT Code Unlocks Pediatric Pipeline
March 19, 2026
12
NeurAxis (NRXS) Q3 2025: 22% Revenue Growth Sets Stage for CPT Code-Driven Inflection
November 11, 2025
12
NeurAxis (NRXS) Q2 2025: 46% Revenue Growth Sets Stage for CPT Code-Driven Inflection
August 12, 2025
11
NeurAxis (NRXS) Q1 2025: 39% Revenue Growth Fueled by Insurance Expansion and CPT Code Milestone
May 12, 2025

Browse all companies